Partnerships and Collaborations
The TREAT-NMD network is incredibly proud and honoured to work with a huge number of partners worldwide. Our collaboration with global partners has resulted in projects that have had a powerful impact on the neuromuscular community, and we continue to forge partnerships to ensure that neuromuscular patients across the globe have access to safe and efficacious therapies and the best standards of care.
We collaborate with patient organisations from across the globe on a wide range of projects including patient facing materials, educational masterclasses, the Global Registry Network and the TREAT-NMD Conference. As neuromuscular patients are at the heart of our mission and everything we aim to achieve, we are grateful for the support and expertise that these wonderful organisations provide.
Our Patient Organisation partners include:
Life Science Industry
The life sciences industry is integral to our work in education and post-marketing surveillance. Industry partners provide support for our education masterclasses and e-learning platform to ensure the best standard of care is given to neuromuscular patients across the globe. In addition, our Advisory Committee for Therapeutics and Post-Authorisation Safety Study (PAESS) projects ensure our mission to support all stages of translational research is realised so that new and ground breaking therapies are made available to the neuromuscular patient population.
The life sciences industry is also integral to the success of the biennial TREAT-NMD International Conference; our partners’ generosity and support ensures we can provide a platform for all stakeholders to inform, inspire and connect.
Our Life Sciences Industry partners include:
We are very proud to work with leading global experts in the neuromuscular field in all aspects of our work. Our key opinion leaders support and contribute to our efforts to improve the lives of those diagnosed with neuromuscular disease.
Our Academic partners include:
Clinical Research Organisations
Our Project Management team works alongside clinical research organisations as an independent partner to support pharmaceutical companies through post-marketing authorisation. Our Post-Authorisation Safety Study (PAESS) projects and effective partnerships ensure that safe and efficacious treatments reach all eligible patients as quickly as possible.
Our Clinical Research Organisation partners include: